;

Search Results:

Showing of 50

CLINICAL TRIAL18331

Selection of Allogeneic Hematopoietic Cell Donors Based on KIR and HLA Genotypes

Cancer Type: Malignant Hematology

View Trial Details

CLINICAL TRIAL17865

SL-401 in Patients with Acute Myeloid Leukemia or Blastic Plasmacytoid Dendritic Cell Neoplasm

Cancer Type: Malignant Hematology

View Trial Details

CLINICAL TRIAL18814

A Multi-Center, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation with Post-Transplantation Cyclophosphamide for Patients with Hematologic Malignancies

Cancer Type: Malignant Hematology

View Trial Details

CLINICAL TRIAL18876

A Phase 1/1b Open-Label Study to Determine the Safety and Tolerability of ALRN-6924 alone and in Combination with Cytarabine (Ara-C) in Patients with Relapsed/Refractory Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome with Wild-Type TP53

Cancer Type: Malignant Hematology

View Trial Details

CLINICAL TRIAL18815

A Phase 2 Study of Tipifarnib in Subjects with Chronic Myelomonocytic Leukemia

Cancer Type: Malignant Hematology

View Trial Details

CLINICAL TRIAL18406

A Phase 1 Study of AZD1775 in Combination with Belinostat in Relapsed and Refractory Myeloid Malignancies and Selected Untreated Patients with Acute Myeloid Leukemia

Cancer Type: Malignant Hematology

View Trial Details

CLINICAL TRIAL18772

A Randomized Multicenter, Open-label, Phase 2 Study Evaluating the Efficacy and Safety of Azacitidine Subcutaneous in Combination With Durvalumab (MEDI4736) in Previously Untreated Subjects with Higher-Risk Myelodysplastic Syndromes (MDS) or in Elderly (>= 65 years) Acute Myeloid Leukemia (AML) Subjects Not Eligible for Hematopoietic Stem Cell Transplantation (HSCT)

Cancer Type: Malignant Hematology

View Trial Details

CLINICAL TRIAL18901

A Prospective, Open Label Phase I/II Study to Assess the Safety and Efficacy of Cycles of Intravenously Infused Doses of OPN-305 in Second-line Lower (Low and intermediate-1) Risk Myelodysplastic Syndrome (MDS)

Cancer Type: Malignant Hematology

View Trial Details

CLINICAL TRIAL18783

A Phase I/II GVHD Prevention Trial Combining Pacritinib With Sirolimus-Based Immune Suppression

Cancer Type: Malignant Hematology

View Trial Details

CLINICAL TRIAL18939

An Open-label, Multicenter Phase 1 Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Splicing Modulator H3B-8800 for Subjects With Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Myelomonocytic Leukemia

Cancer Type: Malignant Hematology

View Trial Details

CLINICAL TRIAL18891

A Multinational Open-Label, Dose Escalation Phase I Study to Assess the Safety and Clinical Activity of Multiple Administrations of NKR-2 in Patients with Different Metastatic Tumor Types

Cancer Type: Malignant Hematology

View Trial Details

CLINICAL TRIAL18950

A Phase I/Ib Study of Ipilimumab or Nivolumab in Patients with Relapsed Hematologic Malignancies after Allogeneic Hematopoietic Cell Transplantation

Cancer Type: Malignant Hematology

View Trial Details

CLINICAL TRIAL19136

Randomized Phase II Study To Assess The Role Of Nivolumab As Single Agent To Eliminate Minimal Residual Disease And Maintain Remission In Acute Myelogenous Leukemia (AML) Patients After Chemotherapy (REMAIN TRIAL)

Cancer Type: Malignant Hematology

View Trial Details

CLINICAL TRIAL18599

A Phase 2, International, Multicenter,Randomized, Open-Label, Parallel Group Study to Evaluate the Efficacy and Safety of CC-486 (Oral Azacitidine) Alone and in Combination with Durvalumab (Medi4736) in Subjects with Myelodysplastic Syndromes who Fail to Achieve an Objective Response to Treatment with Azacitidine for Injection or Decitabine

Cancer Type: Malignant Hematology

View Trial Details

CLINICAL TRIAL18973

A Phase 1b/2 Study to Evaluate the Safety and Efficacy of APR-246 in Combination with Azacitidine for the Treatment of TP53 Mutant Myeloid Neoplasms

Cancer Type: Malignant Hematology

View Trial Details

CLINICAL TRIAL18926

The National Myelodysplastic Syndromes (MDS) Study

Cancer Type: Malignant Hematology

View Trial Details

CLINICAL TRIAL19143

A Randomized, Multi-Center, Phase III Trial of Calcineurin Inhibitor-Free Interventions for Prevention of Graft-versus Host-Disease

Cancer Type: Malignant Hematology

View Trial Details